CSIMarket
 


Avadel Pharmaceuticals Plc  (AVDL)
Other Ticker:  
 


Avadel Pharmaceuticals Plc's Net Cash Flow Margin by quarter

Trends, Rankings, Statistics



AVDL Net Cash Flow Margin (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Revenue Change - - - - -
Seq. Revenue Change 368.85 % - - - -
Revenue In Millions $7.01 $1.50 $0.00 $0.00 $0.00
Net Cash Flow Margin 26.03 % -2233.02 % - - -
Net Cash Flow Margin Total Ranking # 662 # # # # 1
Net Cash Flow In Millions $1.83 $-33.41 $9.41 $13.27 $6.59
Y / Y Net Cash Flow Change -72.28 % - - - -
Seq. Net Cash Flow Change - - - - -


Commenting Third Quarter 2023 Net Cash Flow Margin
Company's Net Cash Flow Margin improved in III. Quarter to 26.03 %, below company's average Net Cash Flow Margin.

Observing third quarter 2023 results within Major Pharmaceutical Preparations industry 80 other companies have achieved higher Net Cash Flow Margin. While Net Cash Flow Margin overall ranking has deteriorated compare to previous quarter from to 662.

AVDL's Net Cash Flow Margin third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 81
Healthcare Sector # 162
Overall # 660

Net Cash Flow Margin Statistics
High Average Low
520.56 % 175.03 % 1.86 %
(Mar 31 2020)  




Other Net Cash Flow Margin Profitability Ratios
AVDL's Cumulative Net Cash Flow Margin
Major Pharmaceutical Preparations Industry Net Cash Flow Margin Trends and Statistics
Healthcare Sector Net Cash Flow Margin Statistics
Net Cash Flow Margin Profitability Trends for overall market
AVDL's Net Cash Flow Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Margin
Lowest Ranking Net Cash Flow Margin
Net Cash Flow Margin Profit Margin for AVDL's Competitors
Net Cash Flow Margin Profit Margin for Avadel Pharmaceuticals Plc's Suppliers
Net Cash Flow Margin Profit Margin for AVDL's Customers

You may also want to know
AVDL's Annual Growth Rates AVDL's Profitability Ratios AVDL's Asset Turnover Ratio AVDL's Dividend Growth
AVDL's Roe AVDL's Valuation Ratios AVDL's Financial Strength Ratios AVDL's Net Cash Flow Growth
AVDL's Roa AVDL's Inventory Turnover Ratio AVDL's Growth Rates AVDL's Dividend Comparisons


Companies with similar Net Cash Flow Margin in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Net Cash Flow MarginSep 30 2023 MRQ Net Cash FlowSep 30 2023 MRQ Revenue
Heron Therapeutics Inc   68.52 %$ 21.397 $ 31.226 
Revance Therapeutics Inc   67.08 %$ 38.084 $ 56.776 
Arvinas Inc   66.76 %$ 23.100 $ 34.600 
Amphastar Pharmaceuticals Inc   66.33 %$ 119.757 $ 180.556 
Spero Therapeutics Inc   63.34 %$ 16.135 $ 25.473 
Deciphera Pharmaceuticals Inc   62.77 %$ 27.186 $ 43.313 
Nektar Therapeutics  58.78 %$ 14.193 $ 24.144 
Amarin Corp Plcuk  57.25 %$ 37.819 $ 66.056 
Dar Bioscience Inc   56.53 %$ 0.565 $ 1.000 
Innoviva Inc   51.43 %$ 35.948 $ 69.899 
Amicus Therapeutics inc   50.65 %$ 51.939 $ 102.555 
Alnylam Pharmaceuticals Inc   50.00 %$ 375.234 $ 750.530 
Clever Leaves Holdings Inc   47.48 %$ 1.397 $ 2.942 
Supernus Pharmaceuticals inc   45.67 %$ 70.279 $ 153.880 
Spruce Biosciences Inc   42.92 %$ 1.319 $ 3.073 
Puma Biotechnology Inc   38.84 %$ 21.793 $ 56.116 
Vertex Pharmaceuticals Inc  38.78 %$ 963.200 $ 2,483.500 
Neptune Wellness Solutions Inc   38.57 %$ 3.371 $ 8.740 
Arrowhead Pharmaceuticals Inc   33.57 %$ 5.404 $ 16.097 
Abbvie inc   32.51 %$ 4,528.000 $ 13,927.000 
Tg Therapeutics Inc   32.50 %$ 53.896 $ 165.815 
Xencor Inc  31.10 %$ 18.401 $ 59.164 
Ionis Pharmaceuticals Inc  29.84 %$ 43.029 $ 144.207 
Immunogen inc   29.58 %$ 33.548 $ 113.425 
Avadel Pharmaceuticals Plc  26.03 %$ 1.826 $ 7.014 
China Pharma Holdings Inc   25.95 %$ 0.468 $ 1.803 
Avid Bioservices Inc   24.38 %$ 6.176 $ 25.335 
Ani Pharmaceuticals Inc  23.80 %$ 31.371 $ 131.829 
Journey Medical Corporation  22.49 %$ 7.769 $ 34.539 
Ocuphire Pharma Inc   19.88 %$ 2.373 $ 11.935 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com